Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04839705
Other study ID # CL11010-001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 24, 2022
Est. completion date December 2029

Study information

Verified date November 2022
Source Microvention-Terumo, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year angiogram as adjudicated by a core laboratory.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date December 2029
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Key Inclusion Criteria: - Patient must be = 18 at the time of screening - Patient must have a single ruptured or unruptured IA requiring treatment - Patient must sign and date an IRN approved written informed consent prior to initiation of any study procedures Key Exclusion Criteria: - Patient has an IA with characteristics unsuitable for endovascular treatment - Patient has conditions placing them at high risk for ischemic stroke or has exhibited ischemic symptoms such as transient ischemic attacks, minor strokes, or stroke-in-evolution within the prior 30 days - Patient has had an SAH from a non-index IA or other intracranial hemorrhage within 90 days - Patient index IA was previously treated - Patient is pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Device:
WEB
Device: WEB The WEB is an intra-aneurysmal device intended for use in endovascular embolization of intracranial aneurysms. Other Names: • WEB Aneurysm Embolization Device

Locations

Country Name City State
United States Albany Medical Center Albany New York
United States West Virginia University Morgantown West Virginia

Sponsors (1)

Lead Sponsor Collaborator
Microvention-Terumo, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Key Effectiveness Outcome Proportion of subjects with adequate aneurysm occlusion at one year after treatment. 12 Months
Primary Key Safety Outcome Proportion of subjects with death of any nonaccidental cause or any major stroke* within the first 30 days after treatment or major ipsilateral stroke or death due to neurologic cause from day 31 to the 1 year after treatment 12 Months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03207087 - The WEB®-IT China Clinical Study N/A
Active, not recruiting NCT02191618 - The WEB-IT Clinical Study N/A